2018-2025 High Affinity Nerve Growth Factor Receptor Report on Global and United States Market, Status and Forecast, by Players, Types and Applications

March 2018 | 122 pages | ID: 21DBB364068QEN
QYResearch

Abstracts

SUMMARY

This report studies the High Affinity Nerve Growth Factor Receptor market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in global and United States market, and splits the High Affinity Nerve Growth Factor Receptor market by product type and application/end industries.

The global High Affinity Nerve Growth Factor Receptor market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially the United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of High Affinity Nerve Growth Factor Receptor.

United States plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of XX.

Geographically, this report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of High Affinity Nerve Growth Factor Receptor in these regions, from 2013 to 2025 (forecast), covering

• United States
• North America
• Europe
• Asia-Pacific
• South America
• Middle East and Africa

The major players in global and United States market, including

• Array BioPharma Inc
• Astellas Pharma Inc
• AstraZeneca Plc
• Daiichi Sankyo Co Ltd
• Dompe Farmaceutici SpA
• Genzyme Corp
• Handok Inc
• Ignyta Inc
• Loxo Oncology Inc
• Merck & Co Inc
• Nerviano Medical Sciences Srl
• Plexxikon Inc
• Proximagen Ltd
• Rottapharm Biotech Srl
• Sienna Biopharmaceuticals Inc
• Tiziana Life Sciences Plc

On the basis of product, the market is primarily split into

• ASP-7962
• AZD-7451
• BNN-27
• Cenegermin
• CRB-0089
• Others

On the basis on the end users/application, this report covers

• Bile Duct Cancer
• Papillary Thyroid Cancer
• Low Back Pain
• Lung Cancer
• Others

Contents

2018-2025 HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR REPORT ON GLOBAL AND UNITED STATES MARKET, STATUS AND FORECAST, BY PLAYERS, TYPES AND APPLICATIONS

1 METHODOLOGY AND DATA SOURCE

1.1 Methodology/Research Approach
  1.1.1 Research Programs/Design
  1.1.2 Market Size Estimation
  1.1.3 Market Breakdown and Data Triangulation
1.2 Data Source
  1.2.1 Secondary Sources
  1.2.2 Primary Sources
1.3 Disclaimer

2 HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR MARKET OVERVIEW

2.1 High Affinity Nerve Growth Factor Receptor Product Overview
2.2 High Affinity Nerve Growth Factor Receptor Market Segment by Type
  2.2.1 ASP-7962
  2.2.2 AZD-7451
  2.2.3 BNN-27
  2.2.4 Cenegermin
  2.2.5 CRB-0089
  2.2.6 Others
2.3 Global High Affinity Nerve Growth Factor Receptor Product Segment by Type
  2.3.1 Global High Affinity Nerve Growth Factor Receptor Sales (K Pcs) and Growth (%) by Type (2013, 2017 and 2025)
  2.3.2 Global High Affinity Nerve Growth Factor Receptor Sales (K Pcs) and Market Share (%) by Type (2013-2018)
  2.3.3 Global High Affinity Nerve Growth Factor Receptor Revenue (Million USD) and Market Share (%) by Type (2013-2018)
  2.3.4 Global High Affinity Nerve Growth Factor Receptor Price (USD/Pcs) by Type (2013-2018)
2.4 United States High Affinity Nerve Growth Factor Receptor Product Segment by Type
  2.4.1 United States High Affinity Nerve Growth Factor Receptor Sales (K Pcs) and Growth by Type (2013, 2017 and 2025)
  2.4.2 United States High Affinity Nerve Growth Factor Receptor Sales (K Pcs) and Market Share by Type (2013-2018)
  2.4.3 United States High Affinity Nerve Growth Factor Receptor Revenue (Million USD) and Market Share by Type (2013-2018)
  2.4.4 United States High Affinity Nerve Growth Factor Receptor Price (USD/Pcs) by Type (2013-2018)

3 HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR APPLICATION/END USERS

3.1 High Affinity Nerve Growth Factor Receptor Segment by Application/End Users
  3.1.1 Bile Duct Cancer
  3.1.2 Papillary Thyroid Cancer
  3.1.3 Low Back Pain
  3.1.4 Lung Cancer
  3.1.5 Others
3.2 Global High Affinity Nerve Growth Factor Receptor Product Segment by Application
  3.2.1 Global High Affinity Nerve Growth Factor Receptor Sales (K Pcs) and CGAR (%) by Application (2013, 2017 and 2025)
  3.2.2 Global High Affinity Nerve Growth Factor Receptor Sales (K Pcs) and Market Share (%) by Application (2013-2018)
3.3 United States High Affinity Nerve Growth Factor Receptor Product Segment by Application
  3.3.1 United States High Affinity Nerve Growth Factor Receptor Sales (K Pcs) and CGAR (%) by Application (2013, 2017 and 2025)
  3.3.2 United States High Affinity Nerve Growth Factor Receptor Sales (K Pcs) and Market Share (%) by Application (2013-2018)

4 HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR MARKET STATUS AND OUTLOOK BY REGIONS

4.1 Global Market Status and Outlook by Regions
  4.1.1 Global High Affinity Nerve Growth Factor Receptor Market Size and CAGR by Regions (2013, 2017 and 2025)
  4.1.2 North America
  4.1.3 Asia-Pacific
  4.1.4 Europe
  4.1.5 South America
  4.1.6 Middle East and Africa
  4.1.7 United States
4.2 Global High Affinity Nerve Growth Factor Receptor Sales and Revenue by Regions
  4.2.1 Global High Affinity Nerve Growth Factor Receptor Sales (K Pcs) and Market Share (%) by Regions (2013-2018)
  4.2.2 Global High Affinity Nerve Growth Factor Receptor Revenue (Million USD) and Market Share (%) by Regions (2013-2018)
  4.2.3 Global High Affinity Nerve Growth Factor Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  4.2.4 North America High Affinity Nerve Growth Factor Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  4.2.5 Europe High Affinity Nerve Growth Factor Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  4.2.6 Asia-Pacific High Affinity Nerve Growth Factor Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  4.2.7 South America High Affinity Nerve Growth Factor Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
  4.2.8 Middle East and Africa High Affinity Nerve Growth Factor Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  4.2.9 United States High Affinity Nerve Growth Factor Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

5 GLOBAL HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR MARKET COMPETITION BY PLAYERS/MANUFACTURERS

5.1 Global High Affinity Nerve Growth Factor Receptor Sales (K Pcs) and Market Share by Players (2013-2018)
5.2 Global High Affinity Nerve Growth Factor Receptor Revenue (Million USD) and Share by Players (2013-2018)
5.3 Global High Affinity Nerve Growth Factor Receptor Average Price (USD/Pcs) by Players (2013-2018)
5.4 Global Top Players High Affinity Nerve Growth Factor Receptor Manufacturing Base Distribution, Sales Area, Product Types
5.5 High Affinity Nerve Growth Factor Receptor Market Competitive Situation and Trends
  5.5.1 High Affinity Nerve Growth Factor Receptor Market Concentration Rate
  5.5.2 Global High Affinity Nerve Growth Factor Receptor Market Share (%) of Top 3 and Top 5 Players
  5.5.3 Mergers & Acquisitions, Expansion

6 UNITED STATES HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR MARKET COMPETITION BY PLAYERS/MANUFACTURERS

6.1 United States High Affinity Nerve Growth Factor Receptor Sales (K Pcs) and Market Share by Players (2013-2018)
6.2 United States High Affinity Nerve Growth Factor Receptor Revenue (Million USD) and Share by Players (2013-2018)
6.3 United States High Affinity Nerve Growth Factor Receptor Average Price (USD/Pcs) by Players (2013-2018)
6.4 United States High Affinity Nerve Growth Factor Receptor Market Share (%) of Top 3 and Top 5 Players

7 HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR PLAYERS/MANUFACTURERS PROFILES AND SALES DATA

7.1 Array BioPharma Inc
  7.1.1 Company Basic Information, Manufacturing Base and Competitors
  7.1.2 High Affinity Nerve Growth Factor Receptor Product Category, Application and Specification
    7.1.2.1 Product A
    7.1.2.2 Product B
  7.1.3 Array BioPharma Inc High Affinity Nerve Growth Factor Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.1.4 Main Business/Business Overview
7.2 Astellas Pharma Inc
  7.2.1 Company Basic Information, Manufacturing Base and Competitors
  7.2.2 High Affinity Nerve Growth Factor Receptor Product Category, Application and Specification
    7.2.2.1 Product A
    7.2.2.2 Product B
  7.2.3 Astellas Pharma Inc High Affinity Nerve Growth Factor Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.2.4 Main Business/Business Overview
7.3 AstraZeneca Plc
  7.3.1 Company Basic Information, Manufacturing Base and Competitors
  7.3.2 High Affinity Nerve Growth Factor Receptor Product Category, Application and Specification
    7.3.2.1 Product A
    7.3.2.2 Product B
  7.3.3 AstraZeneca Plc High Affinity Nerve Growth Factor Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.3.4 Main Business/Business Overview
7.4 Daiichi Sankyo Co Ltd
  7.4.1 Company Basic Information, Manufacturing Base and Competitors
  7.4.2 High Affinity Nerve Growth Factor Receptor Product Category, Application and Specification
    7.4.2.1 Product A
    7.4.2.2 Product B
  7.4.3 Daiichi Sankyo Co Ltd High Affinity Nerve Growth Factor Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.4.4 Main Business/Business Overview
7.5 Dompe Farmaceutici SpA
  7.5.1 Company Basic Information, Manufacturing Base and Competitors
  7.5.2 High Affinity Nerve Growth Factor Receptor Product Category, Application and Specification
    7.5.2.1 Product A
    7.5.2.2 Product B
  7.5.3 Dompe Farmaceutici SpA High Affinity Nerve Growth Factor Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.5.4 Main Business/Business Overview
7.6 Genzyme Corp
  7.6.1 Company Basic Information, Manufacturing Base and Competitors
  7.6.2 High Affinity Nerve Growth Factor Receptor Product Category, Application and Specification
    7.6.2.1 Product A
    7.6.2.2 Product B
  7.6.3 Genzyme Corp High Affinity Nerve Growth Factor Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.6.4 Main Business/Business Overview
7.7 Handok Inc
  7.7.1 Company Basic Information, Manufacturing Base and Competitors
  7.7.2 High Affinity Nerve Growth Factor Receptor Product Category, Application and Specification
    7.7.2.1 Product A
    7.7.2.2 Product B
  7.7.3 Handok Inc High Affinity Nerve Growth Factor Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.7.4 Main Business/Business Overview
7.8 Ignyta Inc
  7.8.1 Company Basic Information, Manufacturing Base and Competitors
  7.8.2 High Affinity Nerve Growth Factor Receptor Product Category, Application and Specification
    7.8.2.1 Product A
    7.8.2.2 Product B
  7.8.3 Ignyta Inc High Affinity Nerve Growth Factor Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.8.4 Main Business/Business Overview
7.9 Loxo Oncology Inc
  7.9.1 Company Basic Information, Manufacturing Base and Competitors
  7.9.2 High Affinity Nerve Growth Factor Receptor Product Category, Application and Specification
    7.9.2.1 Product A
    7.9.2.2 Product B
  7.9.3 Loxo Oncology Inc High Affinity Nerve Growth Factor Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.9.4 Main Business/Business Overview
7.10 Merck & Co Inc
  7.10.1 Company Basic Information, Manufacturing Base and Competitors
  7.10.2 High Affinity Nerve Growth Factor Receptor Product Category, Application and Specification
    7.10.2.1 Product A
    7.10.2.2 Product B
  7.10.3 Merck & Co Inc High Affinity Nerve Growth Factor Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.10.4 Main Business/Business Overview
7.11 Nerviano Medical Sciences Srl
7.12 Plexxikon Inc
7.13 Proximagen Ltd
7.14 Rottapharm Biotech Srl
7.15 Sienna Biopharmaceuticals Inc
7.16 Tiziana Life Sciences Plc

8 HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR MANUFACTURING COST, INDUSTRIAL CHAIN AND DOWNSTREAM BUYERS

8.1 High Affinity Nerve Growth Factor Receptor Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 High Affinity Nerve Growth Factor Receptor Industrial Chain Analysis
8.4 Downstream Buyers in United States

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS AND MARKET EFFECT FACTORS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Distributors in Untied States
9.3 Market Effect Factors Analysis
  9.3.1 Economic/Political Environmental Change
  9.3.2 Downstream Demand Change
  9.3.3 Technology Progress in Related Industry
  9.3.4 Substitutes Threat

10 GLOBAL HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR MARKET FORECAST

10.1 Global High Affinity Nerve Growth Factor Receptor Sales, Revenue Forecast (2018-2025)
  10.1.1 Global High Affinity Nerve Growth Factor Receptor Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
  10.1.2 Global High Affinity Nerve Growth Factor Receptor Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
10.2 United States High Affinity Nerve Growth Factor Receptor Market Forecast
  10.2.1 United States High Affinity Nerve Growth Factor Receptor Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
  10.2.2 United States High Affinity Nerve Growth Factor Receptor Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
10.3 Global High Affinity Nerve Growth Factor Receptor Forecast by Regions
  10.3.1 North America High Affinity Nerve Growth Factor Receptor Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
  10.3.2 Europe High Affinity Nerve Growth Factor Receptor Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
  10.3.3 Asia-Pacific High Affinity Nerve Growth Factor Receptor Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
  10.3.4 South America High Affinity Nerve Growth Factor Receptor Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
  10.3.5 Middle East and Africa High Affinity Nerve Growth Factor Receptor Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
10.4 High Affinity Nerve Growth Factor Receptor Forecast by Type
  10.4.1 Global High Affinity Nerve Growth Factor Receptor Sales (K Pcs) and Revenue (Million USD) Forecast by Type (2018-2025)
  10.4.2 United States High Affinity Nerve Growth Factor Receptor Sales (K Pcs) and Revenue (Million USD) Forecast by Type (2018-2025)
10.5 High Affinity Nerve Growth Factor Receptor Forecast by Application
  10.5.1 Global High Affinity Nerve Growth Factor Receptor Sales (K Pcs) Forecast by Application (2018-2025)
  10.5.2 United States High Affinity Nerve Growth Factor Receptor Sales (K Pcs) Forecast by Application (2018-2025)

11 RESEARCH FINDINGS AND CONCLUSION

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Figure High Affinity Nerve Growth Factor Receptor Product Picture
Figure Global High Affinity Nerve Growth Factor Receptor Revenue (Million USD) Status and Outlook (2013-2025)
Figure United States High Affinity Nerve Growth Factor Receptor Revenue (Million USD) Status and Outlook (2013-2025)
Figure Product Picture of ASP-7962
Table Major Players of ASP-7962
Figure Global ASP-7962 Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of AZD-7451
Table Major Players of AZD-7451
Figure Global AZD-7451 Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of BNN-27
Table Major Players of BNN-27
Figure Global BNN-27 Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of Cenegermin
Table Major Players of Cenegermin
Figure Global Cenegermin Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of CRB-0089
Table Major Players of CRB-0089
Figure Global CRB-0089 Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of Others
Table Major Players of Others
Figure Global Others Sales (K Pcs) and Growth Rate (%)(2013-2018)
Table Global High Affinity Nerve Growth Factor Receptor Sales (K Pcs) and Growth Rate (%) Comparison by Type (2013, 2017 and 2025)
Table Global High Affinity Nerve Growth Factor Receptor Sales (K Pcs) by Type (2013-2018)
Table Global High Affinity Nerve Growth Factor Receptor Sales Share (%) by Type (2013-2018)
Figure Global High Affinity Nerve Growth Factor Receptor Sales Market Share (%) by Type (2013-2018)
Figure Global High Affinity Nerve Growth Factor Receptor Sales Market Share (%) by Type in 2017
Table Global High Affinity Nerve Growth Factor Receptor Revenue (Million USD) by Type (2013-2018)
Table Global High Affinity Nerve Growth Factor Receptor Revenue Share (%) by Type (2013-2018)
Figure Global High Affinity Nerve Growth Factor Receptor Revenue Share (%) by Type (2013-2018)
Figure 2017 Global High Affinity Nerve Growth Factor Receptor Revenue Market Share (%) by Type
Table Global High Affinity Nerve Growth Factor Receptor Price (USD/Pcs) by Type (2013-2018)
Table United States High Affinity Nerve Growth Factor Receptor Sales (K Pcs) and Growth Rate (%) Comparison by Type (2013, 2017 and 2025)
Table United States High Affinity Nerve Growth Factor Receptor Sales (K Pcs) by Type (2013-2018)
Table United States High Affinity Nerve Growth Factor Receptor Sales Share (%) by Type (2013-2018)
Figure United States High Affinity Nerve Growth Factor Receptor Sales Market Share (%) by Type (2013-2018)
Figure United States High Affinity Nerve Growth Factor Receptor Sales Market Share (%) by Type in 2017
Table United States High Affinity Nerve Growth Factor Receptor Revenue (Million USD) by Type (2013-2018)
Table United States High Affinity Nerve Growth Factor Receptor Revenue Share (%) by Type (2013-2018)
Figure United States High Affinity Nerve Growth Factor Receptor Revenue Share (%)by Type (2013-2018)
Figure 2017 United States High Affinity Nerve Growth Factor Receptor Revenue Market Share (%) by Type
Table United States High Affinity Nerve Growth Factor Receptor Price (USD/Pcs) by Type (2013-2018)
Figure Bile Duct Cancer Examples
Figure Papillary Thyroid Cancer Examples
Figure Low Back Pain Examples
Figure Lung Cancer Examples
Figure Others Examples
Table Global High Affinity Nerve Growth Factor Receptor Sales (K Pcs) Comparison by Application (2013-2025)
Table Global High Affinity Nerve Growth Factor Receptor Sales (K Pcs) by Application (2013-2018)
Table Global High Affinity Nerve Growth Factor Receptor Sales Share (%) by Application (2013-2018)
Figure Global High Affinity Nerve Growth Factor Receptor Sales Market Share (%) by Application (2013-2018)
Figure Global High Affinity Nerve Growth Factor Receptor Sales Market Share (%) by Application in 2017
Table United States High Affinity Nerve Growth Factor Receptor Sales (K Pcs) Comparison by Application (2013-2025)
Table United States High Affinity Nerve Growth Factor Receptor Sales (K Pcs) by Application (2013-2018)
Table United States High Affinity Nerve Growth Factor Receptor Sales Share (%) by Application (2013-2018)
Figure United States High Affinity Nerve Growth Factor Receptor Sales Market Share (%) by Application (2013-2018)
Figure United States High Affinity Nerve Growth Factor Receptor Sales Market Share (%) by Application in 2017
Table Global High Affinity Nerve Growth Factor Receptor Revenue (Million USD) and CAGR Comparison by Regions (2013-2025)
Figure North America High Affinity Nerve Growth Factor Receptor Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure Asia-Pacific High Affinity Nerve Growth Factor Receptor Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure Europe High Affinity Nerve Growth Factor Receptor Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure South America High Affinity Nerve Growth Factor Receptor Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure Middle East and Africa High Affinity Nerve Growth Factor Receptor Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure United States High Affinity Nerve Growth Factor Receptor Revenue (Million USD) and Growth Rate (%)(2013-2025)
Table Global High Affinity Nerve Growth Factor Receptor Sales (K Pcs) by Regions (2013-2018)
Table Global High Affinity Nerve Growth Factor Receptor Sales Market Share (%) by Regions (2013-2018)
Figure Global High Affinity Nerve Growth Factor Receptor Sales Market Share (%) by Regions (2013-2018)
Figure 2017 Global High Affinity Nerve Growth Factor Receptor Sales Market Share (%) by Regions
Figure 2017 United States High Affinity Nerve Growth Factor Receptor Sales Market Share (%) in Global Market
Table Global High Affinity Nerve Growth Factor Receptor Revenue (Million USD) by Regions (2013-2018)
Table Global High Affinity Nerve Growth Factor Receptor Revenue Market Share (%) by Regions (2013-2018)
Figure Global High Affinity Nerve Growth Factor Receptor Revenue Market Share (%) by Regions (2013-2018)
Figure 2017 Global High Affinity Nerve Growth Factor Receptor Revenue Market Share (%) by Regions
Figure 2017 United States High Affinity Nerve Growth Factor Receptor Revenue Market Share (%) in Global Market
Table Global High Affinity Nerve Growth Factor Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table North America High Affinity Nerve Growth Factor Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table Europe High Affinity Nerve Growth Factor Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table Asia-Pacific High Affinity Nerve Growth Factor Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table South America High Affinity Nerve Growth Factor Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table Middle East and Africa High Affinity Nerve Growth Factor Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table United States High Affinity Nerve Growth Factor Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table Global High Affinity Nerve Growth Factor Receptor Sales (K Pcs) of Key Players (2013-2018)
Table Global High Affinity Nerve Growth Factor Receptor Sales Share (%) by Players (2013-2018)
Figure 2017 Global High Affinity Nerve Growth Factor Receptor Sales Share (%) by Players
Figure 2018 Global High Affinity Nerve Growth Factor Receptor Sales Share (%) by Players
Table Global High Affinity Nerve Growth Factor Receptor Revenue (Million USD) by Players (2013-2018)
Table Global High Affinity Nerve Growth Factor Receptor Revenue Share (%) by Players (2013-2018)
Table 2017 Global High Affinity Nerve Growth Factor Receptor Revenue Share (%) by Players
Table 2018 Global High Affinity Nerve Growth Factor Receptor Revenue Share (%) by Players
Table Global Market High Affinity Nerve Growth Factor Receptor Average Price (USD/Pcs) by Players (2013-2018)
Table Global High Affinity Nerve Growth Factor Receptor Top Players Manufacturing Base Distribution and Sales Area
Table Global High Affinity Nerve Growth Factor Receptor Top Players Product Category
Figure Global High Affinity Nerve Growth Factor Receptor Market Share (%) of Top 3 Players
Figure Global High Affinity Nerve Growth Factor Receptor Market Share (%) of Top 5 Players
Table United States High Affinity Nerve Growth Factor Receptor Sales (K Pcs) by Players (2013-2018)
Table United States High Affinity Nerve Growth Factor Receptor Sales Market Share (%) by Players (2013-2018)
Figure 2017 United States High Affinity Nerve Growth Factor Receptor Sales Share (%) by Players
Figure 2018 United States High Affinity Nerve Growth Factor Receptor Sales Share (%) by Players
Table United States High Affinity Nerve Growth Factor Receptor Revenue (Million USD) by Players (2013-2018)
Table United States High Affinity Nerve Growth Factor Receptor Revenue Market Share (%) by Players (2013-2018)
Table 2017 United States High Affinity Nerve Growth Factor Receptor Revenue Share (%) by Players
Table 2018 United States High Affinity Nerve Growth Factor Receptor Revenue Share (%) by Players
Table United States Market High Affinity Nerve Growth Factor Receptor Average Price (USD/Pcs) by Players (2013-2018)
Figure United States High Affinity Nerve Growth Factor Receptor Market Share (%) of Top 3 Players
Figure United States High Affinity Nerve Growth Factor Receptor Market Share (%) of Top 5 Players
Table Array BioPharma Inc Basic Information List
Table Array BioPharma Inc High Affinity Nerve Growth Factor Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Array BioPharma Inc High Affinity Nerve Growth Factor Receptor Sales Growth Rate (2013-2018)
Figure Array BioPharma Inc High Affinity Nerve Growth Factor Receptor Sales Global Market Share (%)(2013-2018)
Figure Array BioPharma Inc High Affinity Nerve Growth Factor Receptor Revenue Global Market Share (%)(2013-2018)
Table Astellas Pharma Inc Basic Information List
Table Astellas Pharma Inc High Affinity Nerve Growth Factor Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Astellas Pharma Inc High Affinity Nerve Growth Factor Receptor Sales Growth Rate (2013-2018)
Figure Astellas Pharma Inc High Affinity Nerve Growth Factor Receptor Sales Global Market Share (%)(2013-2018)
Figure Astellas Pharma Inc High Affinity Nerve Growth Factor Receptor Revenue Global Market Share (%)(2013-2018)
Table AstraZeneca Plc Basic Information List
Table AstraZeneca Plc High Affinity Nerve Growth Factor Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure AstraZeneca Plc High Affinity Nerve Growth Factor Receptor Sales Growth Rate (2013-2018)
Figure AstraZeneca Plc High Affinity Nerve Growth Factor Receptor Sales Global Market Share (%)(2013-2018)
Figure AstraZeneca Plc High Affinity Nerve Growth Factor Receptor Revenue Global Market Share (%)(2013-2018)
Table Daiichi Sankyo Co Ltd Basic Information List
Table Daiichi Sankyo Co Ltd High Affinity Nerve Growth Factor Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Daiichi Sankyo Co Ltd High Affinity Nerve Growth Factor Receptor Sales Growth Rate (2013-2018)
Figure Daiichi Sankyo Co Ltd High Affinity Nerve Growth Factor Receptor Sales Global Market Share (%)(2013-2018)
Figure Daiichi Sankyo Co Ltd High Affinity Nerve Growth Factor Receptor Revenue Global Market Share (%)(2013-2018)
Table Dompe Farmaceutici SpA Basic Information List
Table Dompe Farmaceutici SpA High Affinity Nerve Growth Factor Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Dompe Farmaceutici SpA High Affinity Nerve Growth Factor Receptor Sales Growth Rate (2013-2018)
Figure Dompe Farmaceutici SpA High Affinity Nerve Growth Factor Receptor Sales Global Market Share (%)(2013-2018)
Figure Dompe Farmaceutici SpA High Affinity Nerve Growth Factor Receptor Revenue Global Market Share (%)(2013-2018)
Table Genzyme Corp Basic Information List
Table Genzyme Corp High Affinity Nerve Growth Factor Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Genzyme Corp High Affinity Nerve Growth Factor Receptor Sales Growth Rate (2013-2018)
Figure Genzyme Corp High Affinity Nerve Growth Factor Receptor Sales Global Market Share (%)(2013-2018)
Figure Genzyme Corp High Affinity Nerve Growth Factor Receptor Revenue Global Market Share (%)(2013-2018)
Table Handok Inc Basic Information List
Table Handok Inc High Affinity Nerve Growth Factor Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Handok Inc High Affinity Nerve Growth Factor Receptor Sales Growth Rate (2013-2018)
Figure Handok Inc High Affinity Nerve Growth Factor Receptor Sales Global Market Share (%)(2013-2018)
Figure Handok Inc High Affinity Nerve Growth Factor Receptor Revenue Global Market Share (%)(2013-2018)
Table Ignyta Inc Basic Information List
Table Ignyta Inc High Affinity Nerve Growth Factor Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Ignyta Inc High Affinity Nerve Growth Factor Receptor Sales Growth Rate (2013-2018)
Figure Ignyta Inc High Affinity Nerve Growth Factor Receptor Sales Global Market Share (%)(2013-2018)
Figure Ignyta Inc High Affinity Nerve Growth Factor Receptor Revenue Global Market Share (%)(2013-2018)
Table Loxo Oncology Inc Basic Information List
Table Loxo Oncology Inc High Affinity Nerve Growth Factor Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Loxo Oncology Inc High Affinity Nerve Growth Factor Receptor Sales Growth Rate (2013-2018)
Figure Loxo Oncology Inc High Affinity Nerve Growth Factor Receptor Sales Global Market Share (%)(2013-2018)
Figure Loxo Oncology Inc High Affinity Nerve Growth Factor Receptor Revenue Global Market Share (%)(2013-2018)
Table Merck & Co Inc Basic Information List
Table Merck & Co Inc High Affinity Nerve Growth Factor Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Merck & Co Inc High Affinity Nerve Growth Factor Receptor Sales Growth Rate (2013-2018)
Figure Merck & Co Inc High Affinity Nerve Growth Factor Receptor Sales Global Market Share (%)(2013-2018)
Figure Merck & Co Inc High Affinity Nerve Growth Factor Receptor Revenue Global Market Share (%)(2013-2018)
Table Nerviano Medical Sciences Srl Basic Information List
Table Plexxikon Inc Basic Information List
Table Proximagen Ltd Basic Information List
Table Rottapharm Biotech Srl Basic Information List
Table Sienna Biopharmaceuticals Inc Basic Information List
Table Tiziana Life Sciences Plc Basic Information List
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of High Affinity Nerve Growth Factor Receptor
Figure High Affinity Nerve Growth Factor Receptor Industrial Chain Analysis
Table Major Buyers of High Affinity Nerve Growth Factor Receptor
Table Distributors/Traders List
Figure Global High Affinity Nerve Growth Factor Receptor Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Global High Affinity Nerve Growth Factor Receptor Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
Figure United States High Affinity Nerve Growth Factor ReceptorHigh Affinity Nerve Growth Factor Receptor Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure United States High Affinity Nerve Growth Factor Receptor Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
Table Global High Affinity Nerve Growth Factor Receptor Sales (K Pcs) Forecast by Regions (2018-2025)
Figure Global High Affinity Nerve Growth Factor Receptor Sales Market Share (%) Forecast by Regions (2018-2025)
Figure North America High Affinity Nerve Growth Factor Receptor Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure North America High Affinity Nerve Growth Factor Receptor Revenue and Growth Rate (%) Forecast (2018-2025)
Figure Europe High Affinity Nerve Growth Factor Receptor Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Europe High Affinity Nerve Growth Factor Receptor Revenue and Growth Rate (%) Forecast (2018-2025)
Figure Asia-Pacific High Affinity Nerve Growth Factor Receptor Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Asia-Pacific High Affinity Nerve Growth Factor Receptor Revenue and Growth Rate (%) Forecast (2018-2025)
Figure South America High Affinity Nerve Growth Factor Receptor Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure South America High Affinity Nerve Growth Factor Receptor Revenue and Growth Rate (%) Forecast (2018-2025)
Figure Middle East and Africa High Affinity Nerve Growth Factor Receptor Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Middle East and Africa High Affinity Nerve Growth Factor Receptor Revenue and Growth Rate (%) Forecast (2018-2025)
Table Global High Affinity Nerve Growth Factor Receptor Sales (Million USD) Forecast by Type (2018-2025)
Figure Global High Affinity Nerve Growth Factor Receptor Sales Market Share (%) Forecast by Type (2018-2025)
Table Global High Affinity Nerve Growth Factor Receptor Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global High Affinity Nerve Growth Factor Receptor Revenue Market Share (%) Forecast by Type (2018-2025)
Table United States High Affinity Nerve Growth Factor Receptor Sales (Million USD) Forecast by Type (2018-2025)
Figure United States High Affinity Nerve Growth Factor Receptor Sales Market Share (%) Forecast by Type (2018-2025)
Table United States High Affinity Nerve Growth Factor Receptor Revenue (Million USD) Forecast by Type (2018-2025)
Figure United States High Affinity Nerve Growth Factor Receptor Revenue Market Share (%) Forecast by Type (2018-2025)
Table Global High Affinity Nerve Growth Factor Receptor Sales (K Pcs) Forecast by Application (2018-2025)
Figure Global High Affinity Nerve Growth Factor Receptor Sales Forecast by Application (2018-2025)
Table United States High Affinity Nerve Growth Factor Receptor Sales (K Pcs) Forecast by Application (2018-2025)
Figure United States High Affinity Nerve Growth Factor Receptor Sales Forecast by Application (2018-2025)